Treatment of Relapsed and Refractory ALK-Positive Anaplastic Large Cell Lymphoma With ALK-Specific Tyrosine Kinase Inhibitor in Children: A Case Series

Shen, DY; Song, H; Zhang, JY; Liao, C; Wang, Y; Fang, MX; Tang, YM

Tang, YM (通讯作者),Zhejiang Univ, Sch Med,Childrens Hosp, Natl Clin Res Ctr Child Hlth,Pediat Leukemia Diag, Dept Hematol & Oncol,Pediat Hematol Oncol Ctr, 57 Zhuganxiang, Hangzhou, Peoples R China.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2022; 44 (1): E1

Abstract

Relapsed and refractory ALK-positive anaplastic large cell lymphoma (ALCL) has a poor prognosis. In this report, we present 3 relapsed/refractory pedi......

Full Text Link